A carregar...
Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?
BACKGROUND: In daily clinical setting, some patients affected by relapsing-remitting Multiple Sclerosis (RRMS) are switched from the low-dose to the high-dose Interferon beta (IFNB) in order to achieve a better control of the disease. PURPOSE: In this observational, post-marketing study we reported...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3058026/ https://ncbi.nlm.nih.gov/pubmed/21352517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-11-26 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|